메뉴 건너뛰기




Volumn 97, Issue 2-3, 2010, Pages 173-179

A comparative study of European rare disease and orphan drug markets

Author keywords

Comparative analysis; Europe; Health policy; Orphan drug; Rare disease

Indexed keywords

ORPHAN DRUG;

EID: 77956169455     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.05.017     Document Type: Article
Times cited : (86)

References (19)
  • 1
    • 0003187521 scopus 로고    scopus 로고
    • European Commission. European Commission Regulation (EC) No 141/2000 of the European Parliament and the Council of 16 December 1999 on orphan medicinal products
    • L
    • European Commission. European Commission Regulation (EC) No 141/2000 of the European Parliament and the Council of 16 December 1999 on orphan medicinal products. Official Journal of the European Communities 2000, L18(1).
    • (2000) Official Journal of the European Communities , vol.18 , Issue.1
  • 5
    • 1642571450 scopus 로고    scopus 로고
    • Organisation for Economic Co-operation and Development, Paris, Organisation for Economic Co-operation and Development
    • Organisation for Economic Co-operation and Development Health at a glance 2007 2007, Organisation for Economic Co-operation and Development, Paris.
    • (2007) Health at a glance 2007
  • 6
    • 77956178667 scopus 로고    scopus 로고
    • National Institute for Health and Disability Insurance, Brussels, National Institute for Health and Disability Insurance
    • National Institute for Health and Disability Insurance Pharmaceutical specialties 2009, National Institute for Health and Disability Insurance, Brussels.
    • (2009) Pharmaceutical specialties
  • 8
    • 77956180279 scopus 로고    scopus 로고
    • Orphan drugs in Italy. Accommodating orphan drugs: balancing innovation and financial stability
    • Folino Gallo P. Orphan drugs in Italy. Accommodating orphan drugs: balancing innovation and financial stability. Presentation at the Office of Health Economics 2008.
    • (2008) Presentation at the Office of Health Economics
    • Folino Gallo, P.1
  • 10
    • 77956181250 scopus 로고    scopus 로고
    • Dental and Pharmaceutical Benefits Agency
    • Dental and Pharmaceutical Benefits Agency Medicinal products database 2009, http://www.tlv.se/in-english.
    • (2009) Medicinal products database
  • 11
    • 34447263989 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence
    • National Institute for Health and Clinical Excellence Appraising orphan drugs 2006, http://www.nice.org.uk/niceMedia/pdf/smt/120705item4.pdf.
    • (2006) Appraising orphan drugs
  • 13
    • 3542998742 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence and its value judgments
    • Rawlins M.D., Culyer A.J. National Institute for Clinical Excellence and its value judgments. British Medical Journal 2004, 329:224-227.
    • (2004) British Medical Journal , vol.329 , pp. 224-227
    • Rawlins, M.D.1    Culyer, A.J.2
  • 14
    • 38149110959 scopus 로고    scopus 로고
    • Scottish Medicines Consortium
    • Scottish Medicines Consortium Orphan drugs 2007, http://www.scottishmedicines.org.uk/smc/3869.html.
    • (2007) Orphan drugs
  • 18
    • 31544452135 scopus 로고    scopus 로고
    • Is the current approach to reviewing new medicines condemning the victims of rare diseases to death? A call for a national orphan medicine review policy
    • Clarke J. Is the current approach to reviewing new medicines condemning the victims of rare diseases to death? A call for a national orphan medicine review policy. Canadian Medical Association Journal 2006, 174:189-190.
    • (2006) Canadian Medical Association Journal , vol.174 , pp. 189-190
    • Clarke, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.